Medications for Bacterial Pneumonia

8 results

Avycaz (ceftazidime, avibactam)

(ceftazidime, avibactam)
Allergan, Inc.
Usage: AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), and hospital-acquired/ventilator-associated bacterial pneumonia in patients from 31 weeks gestational age, caused by specific susceptible gram-negative bacteria. It aims to reduce drug-resistant bacteria development.

Fetroja (cefiderocol sulfate tosylate)

(Cefiderocol sulfate tosylate)
Shionogi Inc.
Usage: FETROJA is indicated for adults with complicated urinary tract infections (cUTIs), including pyelonephritis, and hospital-acquired or ventilator-associated bacterial pneumonia, caused by specific susceptible Gram-negative bacteria. It should be used judiciously to prevent drug-resistant bacteria development.

Recarbrio (imipenem anhydrous, cilastatin, and relebactam anhydrous)

(imipenem anhydrous, cilastatin, and relebactam anhydrous)
Merck Sharp & Dohme LLC
Usage: RECARBRIO™ is indicated for adults with hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections, and complicated intra-abdominal infections caused by specific susceptible gram-negative microorganisms, particularly when alternative treatment options are limited or unavailable.

Tetracycline (tetracycline hydrochloride)

(Tetracycline Hydrochloride)
Aspen Veterinary Resources
Usage: This drug is indicated for the control and treatment of bacterial enteritis, pneumonia in swine and calves, chronic respiratory disease and infectious synovitis in poultry. It is effective against various pathogens sensitive to tetracycline hydrochloride. Usage varies by species and condition but generally administer in drinking water for a specified duration.

Vibativ (telavancin hydrochloride)

(telavancin hydrochloride)
Theravance, Inc.
Usage: VIBATIV is indicated for treating complicated skin and skin structure infections (cSSSI) and hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP) in adults caused by susceptible Gram-positive bacteria. It should be used to prevent drug-resistant bacteria and tailored based on culture results or local epidemiology when necessary.

Vibativ (telavancin hydrochloride)

(telavancin hydrochloride)
Cumberland Pharmaceuticals Inc.
Usage: VIBATIV is indicated for treating adults with complicated skin and skin structure infections (cSSSI) and hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-positive microorganisms. It may be used as empiric therapy, with consideration for local resistance patterns and bacteriological results.

Xacduro (sulbactam and durlobactam)

(sulbactam and durlobactam)
La Jolla Pharmaceutical Company
Usage: XACDURO is indicated for treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in patients 18 years and older, specifically caused by susceptible isolates of *Acinetobacter baumannii-calcoaceticus* complex. It should only be used to combat infections confirmed or suspected to be due to these bacteria.

Zerbaxa (ceftolozane and tazobactam)

(ceftolozane and tazobactam)
Merck Sharp & Dohme LLC
Usage: ZERBAXA is indicated for the treatment of complicated intra-abdominal infections, complicated urinary tract infections (including pyelonephritis), and hospital-acquired or ventilator-associated bacterial pneumonia in adults and pediatric patients caused by specific susceptible Gram-negative and Gram-positive microorganisms.